Parkinson's Disease Centre and Movement Disorders Clinic, Baylor College of Medicine, McNair Campus, 7200 Cambridge Street, Suite 9A, Houston, TX 77030, USA.
- Subhashie Wijemanne &
- Joseph Jankovic
S.W. wrote the first draft of the article. S.W. and J.J. researched data for the article, made substantial contributions to discussion of content, and reviewed and/or edited the manuscript before submission.
Competing interests statement
J.J. has received Research and Centre of Excellence Grants from Allergan, Auspex Pharmaceuticals, GE Healthcare, Great Lakes NeuroTechnologies, Ipsen, Kyowa Hakko Kirin Pharma, Lundbeck, Medtronic, Merz, Omeros, Pharma Two B, Prothena, Psyadon Pharmaceuticals, St. Jude Medical, Teva Pharmaceutical Industries and UCB. He receives royalty payments from Cambridge University Press, Elsevier, Future Science Group, Hodder Education, Lippincott Williams and Wilkins, and Wiley Blackwell. S.W. declares no competing interests.
Subhashie Wijemanne is an Instructor of Neurology at the Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA. She graduated from the University of Peradeniya, Sri Lanka, in 2000, and completed a neurology residency at Tufts University in Boston, MA, USA in 2012 and a 2 year fellowship at the Parkinson's Disease Center and Movement Disorders Clinic at Baylor College of Medicine in 2014. She is a neurologist certified by the American Board of Neurology. Her research interests include dystonia, Tourette syndrome, restless legs syndrome, catatonia and Parkinson disease.
Joseph Jankovic is Professor of Neurology, Distinguished Chair in Movement Disorders, and Director of the Parkinson's Disease Center and Movement Disorders Clinic at the Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. He leads a clinical and research team that focuses on the aetiology and pathophysiology of movement disorders and experimental therapeutics for Parkinson disease and related disorders. He is former president of the International Parkinson and Movement Disorder Society and an Honorary Member of the American Neurological Association, Australian Association of Neurologists, and other distinguished associations. His honours include the American Academy of Neurology Movement Disorders Research Award. He has been the principal investigator for numerous clinical trials and has published over 1,000 original articles and over 50 books. He serves or has served on the scientific and medical advisory boards of numerous national and international foundations, including the Dystonia Medical Research Foundation, the Michael J. Fox Foundation for Parkinson's Research, and the National Parkinson Foundation.